Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Suxonium is a short-acting depolarizing neuromuscular blocking agent used in anaesthesia as a muscle relaxant. It helps facilitate endotracheal intubation, supports mechanical ventilation, and assists in a wide range of surgical and obstetric procedures.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Suxamethonium is a muscle relaxant. It acts as a depolarizing neuromuscular blocker by imitating the action of acetylcholine at the neuromuscular junction. Suxamethonium acts on muscle type nicotinic receptors. When it binds to the nicotinic acetylcholine receptor, the receptor's nicotinic sodium channel opens; sodium moves into the cell, a disorganized depolarization of the motor-end plate occurs, and calcium is released from the sarcoplasmic reticulum. This results in fasciculation. In a normal muscle, following depolarization, acetylcholine is rapidly hydrolyzed by acetylcholinesterase, allowing the muscle cell to 'reset' and ready itself for the next signal. Suxamethonium, however, is degraded not by acetylcholinesterase but by butyrylcholinesterase, a plasma cholinesterase, and this hydrolysis is much slower than that of acetylcholine by acetylcholinesterase. As a result, Suxamethonium has a longer duration of effect than acetylcholine; it does not allow the muscle cell to 'reset' and keeps the 'new' resting membrane potential below threshold. When acetylcholine then binds to an already depolarized receptor, it cannot cause further depolarization. Calcium is removed from the muscle cell cytosol independent of repolarization, and as it is taken up by the sarcoplasmic reticulum, the muscle relaxes. This explains why flaccidity, rather than tetany, follows the fasciculation.

Pregnancy & Breastfeeding

Suxamethonium doesn't cross the placenta easily, but it's still best avoided during pregnancy unless the doctor feels the benefits clearly outweigh the risks.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Suxamethonium Chloride is usually given by bolus intravenous or intramuscular injection. Adults: The dose of Suxamethonium depends on body weight, the degree of muscle relaxation required, the route of administration, and how the individual patient responds. To achieve endotracheal intubation, Suxamethonium is usually given intravenously at a dose of 1 mg/kg. This dose usually produces muscle relaxation within about 30 to 60 seconds and lasts about 2 to 6 minutes. Supplementary doses of 50% to 100% of the initial dose, given at intervals of 5 to 10 minutes, will maintain muscle relaxation during short surgical procedures performed under general anesthesia. For prolonged surgical procedures, Suxamethonium may instead be given by intravenous infusion as a 0.1% to 0.2% solution, diluted in 5% glucose solution or sterile isotonic saline solution, at a rate of 2.5 to 4 mg per minute. The infusion rate should be adjusted according to how the individual patient responds. The total dose given by repeated intravenous injection or continuous infusion should not exceed 500 mg per hour. Children: Infants and young children are more resistant to Suxamethonium than adults. The recommended intravenous dose for infants is 2 mg/kg. A dose of 1 mg/kg is recommended for older children. When given as an intravenous infusion in children, the dosage follows the adult regimen, with a proportionately lower initial infusion rate based on body weight. Suxamethonium may be given intramuscularly to infants at doses of up to 4 to 5 mg/kg, and to older children at doses of up to 4 mg/kg. These doses produce muscle relaxation within about 3 minutes. A total dose of 150 mg should not be exceeded.

Side Effects & Interactions